This intriguing idea was further supported by: (1) targeting IGF-IR prevented MPN in AIRAPL-deficient mice as well as in mice carrying the Jak2V617F mutation; and (2) the expression of AIRAPL was found to be commonly lacking in human MPN samples [174]. Here, ZFAND2B is linked to myeloproliferative disorder.